Concepedia

Roderick McPhee

RM

13

Publications

1.4K

Citations

12

H-Index

1994

Active since

Affiliations

Moderna Therapeutics (United States)(Current)

Benchmark Research (United States)

Wayne State University

Vanderbilt University Medical Center

Henry Ford Health System

Roderick McPhee is an author at Moderna Therapeutics (United States) specializing in medicine, immunology, and virology.

ORCID

Top concepts

Publications per year

1994–2022

13

Publications

13

Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis

Angela Choi, Matthew Koch, Laurence Chu et al. · Nature Medicine · 2021 · 446 citations · Full text

A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine

Laurence Chu, Roderick McPhee, Wenmei Huang et al. · Vaccine · 2021 · 229 citations · Full text

Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age

C. Buddy Creech, Evan J. Anderson, Vladimir Berthaud et al. · New England Journal of Medicine · 2022 · 170 citations · Full text

Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age

Evan J. Anderson, C. Buddy Creech, Vladimir Berthaud et al. · New England Journal of Medicine · 2022 · 136 citations · Full text

Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial

Laurence Chu, Keith Vrbicky, David C. Montefiori et al. · Nature Medicine · 2022 · 100 citations · Full text

Rows per page

1–5 of 13